AMER1

APC membrane recruitment protein 1, the group of APC membrane recruitment proteins

Basic information

Region (hg38): X:64185117-64205708

Previous symbols: [ "FAM123B" ]

Links

ENSG00000184675NCBI:139285OMIM:300647HGNC:26837Uniprot:Q5JTC6AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • osteopathia striata with cranial sclerosis (Strong), mode of inheritance: XL
  • osteopathia striata with cranial sclerosis (Strong), mode of inheritance: XL
  • osteopathia striata with cranial sclerosis (Definitive), mode of inheritance: XL
  • osteopathia striata with cranial sclerosis (Supportive), mode of inheritance: XL
  • osteopathia striata with cranial sclerosis (Strong), mode of inheritance: XL
  • osteopathia striata with cranial sclerosis (Definitive), mode of inheritance: XL

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Osteopathia striata with cranial sclerosisXLGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingAudiologic/Otolaryngologic; Cardiovascular; Craniofacial; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic19079258; 20209645; 20950377; 22987541

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the AMER1 gene.

  • not provided (14 variants)
  • Osteopathia striata with cranial sclerosis (9 variants)
  • AMER1-related disorder (1 variants)
  • Inborn genetic diseases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the AMER1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
70
clinvar
24
clinvar
95
missense
166
clinvar
48
clinvar
47
clinvar
261
nonsense
7
clinvar
2
clinvar
7
clinvar
16
start loss
1
clinvar
1
frameshift
12
clinvar
6
clinvar
7
clinvar
25
inframe indel
5
clinvar
1
clinvar
6
splice donor/acceptor (+/-2bp)
0
splice region
2
2
non coding
1
clinvar
2
clinvar
3
Total 19 8 188 118 74

Variants in AMER1

This is a list of pathogenic ClinVar variants found in the AMER1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
X-64189879-C-T Osteopathia striata with cranial sclerosis • AMER1-related disorder Benign/Likely benign (Dec 25, 2023)720216
X-64189881-A-G Uncertain significance (Oct 22, 2020)992343
X-64189910-G-A Uncertain significance (Oct 03, 2023)2785968
X-64189912-G-A Likely benign (Dec 26, 2023)2703799
X-64189918-G-C Osteopathia striata with cranial sclerosis Uncertain significance (Nov 12, 2022)2431812
X-64189929-G-A Benign (May 29, 2022)1937096
X-64189951-C-T Benign (Dec 13, 2023)749505
X-64189957-T-C Benign (Jan 16, 2024)1566068
X-64189959-A-T Osteopathia striata with cranial sclerosis Uncertain significance (Aug 08, 2019)1030260
X-64190001-G-A Osteopathia striata with cranial sclerosis Uncertain significance (Dec 02, 2022)2439013
X-64190010-C-T Uncertain significance (Jun 14, 2023)2860087
X-64190013-G-A Uncertain significance (Jan 24, 2024)1930140
X-64190014-C-T Benign (Jan 18, 2024)756273
X-64190016-G-A not specified Benign (Dec 18, 2023)133493
X-64190021-C-G Osteopathia striata with cranial sclerosis Uncertain significance (Apr 20, 2021)2439016
X-64190022-T-C Uncertain significance (Sep 14, 2022)2415802
X-64190039-C-A Uncertain significance (Jun 10, 2023)1922695
X-64190059-C-T Likely benign (Aug 08, 2022)1950483
X-64190061-T-A Colorectal cancer Pathogenic (-)998120
X-64190064-C-T Uncertain significance (Nov 27, 2023)1383015
X-64190071-T-TA Uncertain significance (Jan 31, 2023)2428941
X-64190072-A-G Inborn genetic diseases Uncertain significance (Feb 02, 2022)2274995
X-64190089-G-A Likely benign (Oct 29, 2023)2867219
X-64190111-C-T Uncertain significance (Feb 14, 2023)2805786
X-64190112-TG-T Uncertain significance (Feb 24, 2023)2837922

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
AMER1protein_codingprotein_codingENST00000330258 120628
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.8540.146125690261256980.0000318
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.5694744401.080.00003307382
Missense in Polyphen105126.380.830832172
Synonymous-1.151811621.110.00001142325
Loss of Function4.06528.30.1770.00000266424

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001120.000112
Ashkenazi Jewish0.000.00
East Asian0.00007380.0000544
Finnish0.000.00
European (Non-Finnish)0.00004970.0000352
Middle Eastern0.00007380.0000544
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Regulator of the canonical Wnt signaling pathway. Acts by specifically binding phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2), translocating to the cell membrane and interacting with key regulators of the canonical Wnt signaling pathway, such as components of the beta-catenin destruction complex. Acts both as a positive and negative regulator of the Wnt signaling pathway, depending on the context: acts as a positive regulator by promoting LRP6 phosphorylation. Also acts as a negative regulator by acting as a scaffold protein for the beta- catenin destruction complex and promoting stabilization of Axin at the cell membrane. Promotes CTNNB1 ubiquitination and degradation. Involved in kidney development. {ECO:0000269|PubMed:17510365, ECO:0000269|PubMed:17925383, ECO:0000269|PubMed:19416806, ECO:0000269|PubMed:21304492, ECO:0000269|PubMed:21498506}.;
Pathway
Degradation of beta-catenin by the destruction complex;Degradation of beta-catenin by the destruction complex;Signaling by WNT;Signal Transduction;Disassembly of the destruction complex and recruitment of AXIN to the membrane;Beta-catenin phosphorylation cascade;TCF dependent signaling in response to WNT (Consensus)

Recessive Scores

pRec
0.0852

Intolerance Scores

loftool
rvis_EVS
-0.39
rvis_percentile_EVS
27.03

Haploinsufficiency Scores

pHI
hipred
Y
hipred_score
0.734
ghis
0.470

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
gene_indispensability_score

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Amer1
Phenotype
embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; limbs/digits/tail phenotype; immune system phenotype; skeleton phenotype; renal/urinary system phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype;

Zebrafish Information Network

Gene name
amer1
Affected structure
head
Phenotype tag
abnormal
Phenotype quality
malformed

Gene ontology

Biological process
Wnt signaling pathway;positive regulation of protein ubiquitination;bone development;adipose tissue development;regulation of canonical Wnt signaling pathway;mesenchymal cell differentiation involved in kidney development;negative regulation of canonical Wnt signaling pathway;positive regulation of canonical Wnt signaling pathway;positive regulation of cellular protein catabolic process;beta-catenin destruction complex assembly;beta-catenin destruction complex disassembly
Cellular component
cytosol;plasma membrane;nuclear body;intracellular membrane-bounded organelle
Molecular function
protein binding;phosphatidylinositol-4,5-bisphosphate binding;beta-catenin binding;beta-catenin destruction complex binding